Low-dose radiotherapy synergizes with iRGD-antiCD3-modified T cells by facilitating T cell infiltration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low-dose radiotherapy synergizes with iRGD-antiCD3-modified T cells by facilitating T cell infiltration

Published:2024-05 Issue: Volume:194 Page:110213
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Zhou Shujuan^ORCID,Zhu Mei,Wei Xiao,Mu Peiyuan^ORCID,Shen Lijun,Wang Yan,Wan Juefeng,Zhang Hui^ORCID,Xia Fan,Zhang Zhen

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference32 articles.

1. Migrating into the tumor: a roadmap for T cells;van der Woude;Trends Cancer,2017

2. iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma;Dong;J Transl Med,2023

3. iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer;Ding;Nat Commun,2019

4. DSPE-PEG: a distinctive component in drug delivery system;Che;Curr Pharm Des,2015

5. Harnessing T cells to fight cancer with BiTE(R) antibody constructs–past developments and future directions;Klinger;Immunol Rev,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP